Diagnosis and treatment of idiopathic intracranial hypertension.
Idiopathic intracranial hypertension (IIH)
headache
pain
papilledema
Journal
Cephalalgia : an international journal of headache
ISSN: 1468-2982
Titre abrégé: Cephalalgia
Pays: England
ID NLM: 8200710
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
pubmed:
27
2
2021
medline:
15
12
2021
entrez:
26
2
2021
Statut:
ppublish
Résumé
To review and discuss the clinical presentation and treatment of idiopathic intracranial hypertension. Visual alterations and headache are the two main symptoms of idiopathic intracranial hypertension, although additional features including cranial nerve palsies, cognitive deficits, olfactory deficits and tinnitus are not uncommon. The headache associated with idiopathic intracranial hypertension frequently has a migrainous phenotype. The underlying cause of the disorder has not yet been elucidated. Several hypotheses have been postulated but none of them can explain the full clinical picture. Therapeutic options remain limited, focusing mainly on reduction in body weight and the reduction of CSF production with carbonic anhydrase inhibitors. The accurate diagnosis of idiopathic intracranial hypertension is essential as visual deterioration due to papilledema may be irreversible. Given its phenotypic similarity and frequent overlap with chronic migraine it is essential to consider idiopathic intracranial hypertension in the diagnostic workup of chronic headache; in particular, when considering its increasing prevalence. Understanding in detail the pathophysiological mechanisms behind the associated headache would also allow study of current and future therapeutic options in a structured way.
Identifiants
pubmed: 33631966
doi: 10.1177/0333102421997093
pmc: PMC8020303
doi:
Substances chimiques
Analgesics
0
Acetazolamide
O3FX965V0I
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
472-478Références
Cephalalgia. 2018 Jan;38(1):1-211
pubmed: 29368949
Neurology. 1991 Feb;41(2 ( Pt 1)):239-44
pubmed: 1992368
JAMA. 2014 Apr 23-30;311(16):1641-51
pubmed: 24756514
Neuroophthalmology. 2014 Nov 12;38(6):310-319
pubmed: 27928318
J Headache Pain. 2019 May 23;20(1):59
pubmed: 31122204
J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1088-1100
pubmed: 29903905
Eur J Neurol. 2014 Dec;21(12):1458-64
pubmed: 25070715
Headache. 2017 Sep;57(8):1195-1205
pubmed: 28752894
Eye (Lond). 1998;12 ( Pt 1):111-8
pubmed: 9614526
Brain. 1991 Feb;114 ( Pt 1A):155-80
pubmed: 1998880
Acta Neurol Scand. 2007 Nov;116(5):322-7
pubmed: 17922725
Ann Neurol. 1984 Oct;16(4):489-94
pubmed: 6497356
Cephalalgia. 2019 Feb;39(2):245-253
pubmed: 29911422
J Headache Pain. 2015;16:521
pubmed: 25982204
J Neurol Neurosurg Psychiatry. 2003 Apr;74(4):415-8
pubmed: 12640051
Cephalalgia. 1990 Dec;10(6):331-5
pubmed: 2289234
Neurology. 2015 Jun 16;84(24):2449-56
pubmed: 25995055
Arch Ophthalmol. 1977 Jan;95(1):97-104
pubmed: 189739
Invest Ophthalmol Vis Sci. 2014 Apr 29;55(5):3200-7
pubmed: 24781936
Lancet Neurol. 2016 Jan;15(1):78-91
pubmed: 26700907
Curr Opin Neurol. 2019 Feb;32(1):92-98
pubmed: 30547900
Int Ophthalmol Clin. 1986 Winter;26(4):265-75
pubmed: 3804630
Headache. 2009 Feb;49(2):185-93
pubmed: 19222592
Cephalalgia. 2015 Jun;35(7):553-62
pubmed: 25228684
J Neurol. 2011 May;258(5):874-81
pubmed: 21161260
Ophthalmology. 2011 Feb;118(2):412-4
pubmed: 20801522
Neurology. 2002 May 28;58(10):1551-3
pubmed: 12034799
Acta Neurol Scand. 2013 Jun;127(6):406-12
pubmed: 23278763
JAMA Neurol. 2014 Jun;71(6):693-701
pubmed: 24756302
AJNR Am J Neuroradiol. 2015 Oct;36(10):1899-904
pubmed: 26251432
J Headache Pain. 2018 Oct 8;19(1):93
pubmed: 30298346
J Neuroophthalmol. 2013 Mar;33(1):17-20
pubmed: 22801353
Neurology. 2007 Jan 16;68(3):229-32
pubmed: 17224579